These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8316313)

  • 21. Choice of bronchodilator therapy in chronic obstructive pulmonary disease.
    Rennard SI
    Respirology; 1997; 2 Suppl 1():S11-5. PubMed ID: 9400689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.
    Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
    Thorax; 2005 Jun; 60(6):480-7. PubMed ID: 15923248
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FVC response in bronchoreversibility test.
    Chhabra SK
    Indian J Chest Dis Allied Sci; 2001; 43(1):9-11. PubMed ID: 11370510
    [No Abstract]   [Full Text] [Related]  

  • 24. [Nebulizer in treatment of chronic obstructive lung diseases].
    Khmel'kova NG; Melent'eva EM
    Ter Arkh; 2000; 72(3):50-5. PubMed ID: 10776655
    [No Abstract]   [Full Text] [Related]  

  • 25. Theophylline: taking it to a new level.
    Messerschmidt K
    S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341
    [No Abstract]   [Full Text] [Related]  

  • 26. Indications for continuous aerosol therapy.
    Stiksa G
    Eur J Respir Dis Suppl; 1982; 119():89-96. PubMed ID: 7047189
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhalable drugs for systemic therapy.
    Corkery K
    Respir Care; 2000 Jul; 45(7):831-5. PubMed ID: 10926380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does the mode of inhalation affect the bronchodilator response in patients with severe COPD?
    Eiser NM; Phillips C; Wooler PA
    Respir Med; 2001 Jun; 95(6):476-83. PubMed ID: 11421505
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of acute bronchodilator reversibility in patients with symptoms of GOLD stage I COPD.
    O'Donnell DE; Laveneziana P; Ora J; Webb KA; Lam YM; Ofir D
    Thorax; 2009 Mar; 64(3):216-23. PubMed ID: 19052054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined bronchodilator therapy in the management of chronic obstructive pulmonary disease.
    Friedman M
    Respirology; 1997; 2 Suppl 1():S19-23. PubMed ID: 9400691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinical aspects of anticholinergic agents].
    Friedman M
    Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
    [No Abstract]   [Full Text] [Related]  

  • 32. An overall view.
    Fletcher CM
    Bull Physiopathol Respir (Nancy); 1972; 8(3):726-9. PubMed ID: 4645582
    [No Abstract]   [Full Text] [Related]  

  • 33. Bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airway disease.
    Hahn DL
    N Engl J Med; 1993 Apr; 328(14):1044; author reply 1044-5. PubMed ID: 8450868
    [No Abstract]   [Full Text] [Related]  

  • 34. [Why is Etaphylline not better in chronic aspecific respiratory disease?].
    Zuidema J; Merkus FW
    Ned Tijdschr Geneeskd; 1979 Sep; 123(35):1527-8. PubMed ID: 492369
    [No Abstract]   [Full Text] [Related]  

  • 35. [Is nebulized ipratropium bromide effective in the treatment of exacerbations of chronic obstructive pulmonary disease?].
    Musil J
    Vnitr Lek; 2000 Jan; 46(1):45-8. PubMed ID: 10953664
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Inhaler therapy for adults with obstructive lung diseases: powder or aerosol?].
    Dekhuijzen PN
    Ned Tijdschr Geneeskd; 1998 Jun; 142(24):1369-74. PubMed ID: 9752023
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Does addition of inhaled steroid to combined bronchodilator therapy affect health status in patients with COPD?
    Yildiz F; Basyigit I; Yildirim E; Boyaci H; Ilgazli A
    Respirology; 2004 Aug; 9(3):352-5. PubMed ID: 15363007
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Drug treatment of chronic obstructive pulmonary disease].
    van Herwaarden CL; Dekhuijzen PN; van Schayck CP; van Weel C; Molema J
    Ned Tijdschr Geneeskd; 1996 Apr; 140(14):761-5. PubMed ID: 8668261
    [No Abstract]   [Full Text] [Related]  

  • 39. Quality of life measurements and bronchodilator responsiveness in prescribing nebulizer therapy in COPD.
    Brophy C; Kastelik J; Gardiner E; Greenstone M
    Chron Respir Dis; 2008; 5(1):13-8. PubMed ID: 18303097
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Respiratory stimulants and COPD].
    Izquierdo J; Morera J
    Rev Clin Esp; 1994 Dec; 194(12):1003-5. PubMed ID: 7863044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.